pp60(v-src) transformation of rat cells but not chicken cells strongly correlates with low-affinity phosphopeptide binding by the SH2 domain

Molecular Biology of the Cell

Volumn 8, Issue 5, 1997, Pages 843-854

  Verderame, Michael F ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PHOSPHOPEPTIDE; PROTEIN KINASE P60;

ALLELE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CHICKEN; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT; SPECIES DIFFERENCE; ANIMAL; CELL LINE; CHICK EMBRYO; GENE EXPRESSION; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY; SRC HOMOLOGY DOMAIN;

ANIMALIA; GALLUS GALLUS;

ANIMALS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CHICK EMBRYO; GENE EXPRESSION; MUTATION; ONCOGENE PROTEIN PP60(V-SRC); PHOSPHOPEPTIDES; PROTEIN BINDING; RATS; SPECIES SPECIFICITY; SRC HOMOLOGY DOMAINS;

EID: 0030612112     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.8.5.843     Document Type: Article

References (67)

1. Bibbins, K.B., Boeuf, H., and Varmus, H.E. (1993). Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides. Mol. Cell. Biol. 13, 7278-7287.
2. Boeuf, H., Murphy, J., Bibbins, K.B., and Varmus, H.E. (1995). Binding in vitro of phosphotyrosine-containing proteins to pp60(c-src) SH2 domain does not correlate with CEF cell transformation. Oncogene 10, 433-438.
3. c-src protein kinase activity in human colon carcinoma. Proc. Natl. Acad. Sci. USA 84, 2251-2255.
4. Brown, A.M.C., and Scott, M.R.D. (1987). Retroviral vectors. In: DNA Cloning, ed. D.M. Glover, Oxford, United Kingdom: IRL Press, 189-212.
5. src but does not affect tyrosine protein kinase activity. J. Virol. 58, 468-474.
6. c-src mutated in the carboxy-terminal regulatory domain. Cell 49, 83-91.
7. c-src activation in human colon carcinoma. J. Clin. Invest. 83, 2025-2033.
8. c-src protein kinase is an early event in colonic carcinogenesis. Proc. Natl. Acad. Sci. USA 87, 558-562.
9. csk in T lymphocytes. Mol. Cell. Biol. 15, 5937-5944.
10. fak. Mol. Cell. Biol. 14, 147-155.
11. Cooper, J.A., and Howell, B. (1993). The when and how of Src regulation. Cell 73, 1051-1054.
12. DeClue, J.E., and Martin, G.S. (1989). Linker insertion-deletion mutagenesis of the v-src gene: isolation of host-and temperature-defendent mutants. J. Virol. 63, 542-554.
13. Eck, M.J., Shoelson, S.E., and Harrison, S.C. (1993). Recognition of a high-affinity phosphotyrosyl peptide by the src homology-2 domain of p56(lck). Nature 362, 87-91.
14. Foster, R., and Martin, G.S. (1992). A mutation in the catalytic domain of pp60v-src is responsible for the host-dependent and temperature-dependent phenotype of the Rous sarcoma virus muant tsLA33-1. Virology 187, 145-155.
15. Fumagalli, S., Totty, N.F., Hsuan, J.J., and Courtneidge, S.A. (1994). A target for src in mitosis. Nature 368, 871-874.
16. Garcia, R., Parikh, N.U., Saya, H., and Gallick, G.E. (1991). Effect of herbimycin-A on growth and pp60c-src activity in human colon tumor cell lines. Oncogene 6, 1983-1989.
17. c-src. Mol. Cell. Biol. 10, 1307-1318.
18. Hirai, H., and Varmus, H.E. (1990b). Mutations in src homology regions 2 and 3 of activated chicken c-src that result in preferential transformation of mouse or chicken cells. Proc. Natl. Acad. Sci. USA 87, 8592-8596.
19. Howell, B.W., and Cooper, J.A. (1994). CSK suppression of Src involves movement of CSK to sites of Src activity. Mol. Cell. Biol. 14, 5402-5411.
20. Hughes, S.H., Greenhouse, J.J., Petropoulos, C.J., and Sutrave, P. (1987). Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J. Virol. 61, 3004-3012.
21. Iswashita, S., Kitamura, N., and Yoshida, M. (1983). Molecular events leading to fusiform morphological transformation by partial src deletion mutant of Rous sarcoma virus. Virology 125, 419-431.
22. src prevents both myristoylation and morphological transformation. Proc. Natl. Acad. Sci. USA 82, 4625-4628.
23. Kamps, M.P., Buss, J.E., and Sefton, B.M. (1986). Rous sarcoma virus transforming protein lacking myristic acid phosphorylates known polypeptide substrates without inducing transformation. Cell 45, 105-112.
24. Kaplan, K.B., Bibbins, K.B., Swedlow, J.R., Arnaud, M., Morgan, D.O., and Varmus, H.E. (1994). Association of the amino-terminal half of c-Src with focal adhesions alters their properties and is regulated by phosphorylation of tyrosine 527. EMBO J. 23, 4745-4756.
25. c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 49, 65-73.
26. Koch, C.A., Moran, M.F., Anderson, D., Liu, X., Mbamalu, G., and Pawson, T. (1992). Multiple SH2-mediated interactions in v-src-transformed cells. Mol. Cell. Biol. 12, 1366-1374.
27. Kunkel, T.A. (1985). Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82, 488-442.
28. Ladbury, J.E., Lemmon, M.A., Zhou, M., Green, J., Bofield, M.C., and Schlessinger, J. (1995). Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal. Proc. Natl. Acad. Sci. USA 92, 3199-3203.
29. Liu, X.Q., Brodeur, S.R., Gish, G., Songyang, Z., Cantley, L.C., Laudano, A.P., and Pawson, T. (1993b). Regulation of c-Src tyrosine kinase activity by the src SH2 domain. Oncogene 8, 1119-1126.
30. Liu, X., Marengere, L.E.M., Koch, C.A., and Pawson, T. (1993a). The v-Src SH3 domain binds phosphatidylinositol 3′-kinase. Mol. Cell. Biol. 13, 5225-5232.
31. Marengere, L.E.M., and Pawson, T. (1992). Identification of residues in GTPase-activating protein src homology-2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62. J. Biol. Chem. 267, 22779-22786.
32. Marengere, L.E.M., and Pawson, T. (1994). Structure and function of SH2 domains. J. Cell Sci. Suppl. 18, 97-104.
33. Mayer, B.J., Jackson, P.K., Van Etten, R.A., and Baltimore, D. (1992). Point mutations in the v-abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo. Mol. Cell. Biol. 12, 609-618.
34. McGlade, J., Cheng, A., Pelicci, G., Pelicci, P.G., and Pawson, T. (1992). She proteins are phosphorylated and regulated by the v-Src and v-Fps protein-tyrosine kinases. Proc. Natl. Acad. Sci. USA 89, 8869-8873.
35. Murphy, S.M., Bergman, M., and Morgan, D.O. (1993). Suppression of c-Src activity by C-terminal src kinase involves the c-Src SH2-domain and SH3-domain: analysis with Saccharomyces cerevisiae. Mol. Cell. Biol. 13, 5290-5300.
36. Nemeth, S.P., Fox, L.G., DeMarco, M., and Brugge, J.S. (1989). Deletions within the amino-terminal half of the c-src gene product that alter the functional activity of the protein. Mol. Cell. Biol. 9, 1109-1119.
37. Novotnysmith, C.L., and Gallick, G.E. (1992). Growth inhibition of human colorectal carcinoma cell lines by tumor necrosis factor-alpha correlates with reduced activity of pp60(c-src). J. Immunother. 11, 159-168.
38. c-src by point mutations in the SH2 domain. Mol. Cell. Biol. 10, 2855-2862.
39. Okada, M., Howell, B.W., Broome, M.A., and Cooper, J.A. (1993). Deletion of the SH3 domain of src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine. J. Biol. Chem. 268, 18070-18075.
40. Okamura, H., and Resh, M.D. (1994). Differential binding of pp60(c-src) and pp60(v-src) to cytoskeleton is mediated by SH2 and catalytic domains. Oncogene 9, 2293-2303.
41. fyn. Mol. Cell. Biol. 14, 6372-6385.
42. c-src. Cell 37, 131-139.
43. Parsons, J.T., and Weber, M.J. (1989). Genetics of src: structure and functional organization of a protein tyrosine kinase. Curr. Top. Microbiol. Immunol. 147, 79-127.
44. c-src. Cell 49, 75-82.
45. Resh, M.D. (1993). Interaction of tyrosine kinase oncoproteins with cellular membranes. Biochim. Biophys. Acta 1155, 307-322.
46. src with two tyrosine-phosphorylated cellular proteins. Mol. Cell. Biol. 9, 3951-3958.
47. Sabe, H., Hata, A., Okada, M., Nakagawa, H., and Hanafusa, H. (1994). Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src. Proc. Natl. Acad. Sci. USA 91, 3984-3988.
48. Sakai, R., Iwamatsu, A., Hirano, N., Ogawa, S., Tanaka, T., Mano, H., Yazaki, Y., and Hirai, H. (1994). A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J. 13, 3748-3756.
49. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
50. Schaffhausen, B. (1995). SH2 domain structure and function. Biochim. Biophys. Acta 1242, 61-75.
51. Sefton, B.M., and Hunter, T. (1986). From c-src to v-src, or the case of the missing C terminus. Cancer Surv. 5, 159-172.
52. Seidel-Dugan, C., Meyer, B.E., Thomas, S.E., and Brugge, J.S. (1992). Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src. Mol. Cell. Biol. 12, 1835-1845.
53. v-src. J. Cell Biol. 119, 415-425.
54. Smith, M.R., DeGudicibus, S.J., and Stacey, D.W. (1986). Requirement for c-ras proteins during viral oncogene transformation. Nature 320, 540-543.
55. v-src. Cell 32, 891-901.
56. Songyang, Z., et al. (1993). SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-778.
57. Stacey, D., Roudebush, M., Day, R., Mosser, S.D., Gibbs, J.B., and Feig, L.A. (1991). Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes. Oncogene 6, 2297-2304.
58. Superti-Furga, G., Fumagalli, S., Koegl, M., Courtneidge, S.A., and Draetta, G. (1993). Csk inhibition of c-src activity requires both the SH2 and SH3 domains of src. EMBO J. 12, 2625-2634.
59. Taylor, S., and Shalloway, D. (1994). An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis. Nature 368, 867-871.
60. Tian, M., and Martin, G.S. (1996). Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild type transformation. Oncogene 11, 727-734.
61. v-src autophosphorylation correlate with SHC-GRB2 complex formation in rat and chicken cells expressing host-range and transformation-defective alleles of v-src. Mol. Biol. Cell 6, 953-966.
62. v-src restricts transformation in a host dependent manner. J. Virol. 63, 338-348.
63. Verderame, M.F., and Varmus, H.E. (1994). Highly conserved amino acids in the SH2 and catalytic domains of v-src are altered in naturally occurring, transformation-defective alleles. Oncogene 9, 175-182.
64. Waksman, G., et al. (1992). Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature 358, 646-653.
65. Waksman, G., Shoelson, S.E., Pant, N., Cowburn, D., and Kurivan, J. (1993). Binding of a high affinity phosphotyrosyl peptide to the src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell 72, 779-790.
66. Woods, K.M., and Verderame, M.F. (1994). Autophosphorylation is required for high kinase activity and efficient transforming ability of proteins encoded by host-range alleles of v-src. J. Virol. 68, 7267-7274.
67. Wyke, J.A., and Stoker, A.W. (1987). Genetic analysis of the form and function of the viral src oncogene product. Biochim. Biophys. Acta 907, 47-69.